Mitchell Lab Engineers LNPs to Enhance mRNA Vaccine Efficacy, Reduce Side Effects
Mitchell and his team discovered that lipid nanoparticles (LNPs) can be used to modify the metabolism of immune cells.
Penn Engineering Researchers Use Topology to Build More Robust Photonic Networks
Researchers leveraged topological design principles to develop stable chip networks that guide multiple light signals at once.
NIH Director Jay Bhattacharya and Senator Dave McCormick Visit Penn Medicine
The visit included meetings with researchers, clinicians, and innovators at Penn and a tour of one of Penn’s CAR T cell laboratories.
Penn Engineering Announces the Launch of The Futures Fund Partnership for Innovation
The fund will finance innovative projects at their earliest stages.
Featured Startup: Nairon Energy
Nairon Energy is building high-voltage sodium-iron batteries to strengthen grid resilience and support long-duration energy storage.
Featured Technology: Physical Neural Network for Fast, Scalable, and Power-Efficient Machine Learning Computation
This is hardware-based neural network technology that performs machine learning directly through physical circuits instead of traditional software.
Ultragenyx Reports Promising Phase III Clinical Trial Results for Urea Cycle Disorder Treatment
Ultragenyx’s gene therapy DTX301, based on technology invented by Jim Wilson, MD, PhD, Emeritus Professor at Penn Medicine, helped control ammonia levels in patients with a urea cycle disorder.
Serpent Robotics Wins 2026 President’s Innovation Prize
Serpent Robotics, founded by Wharton undergraduate Margaret Zhu, is developing an electric, rope‑climbing robotic system.
Avisi Technologies Raises $11M to Advance Glaucoma Treatment
The funding will support Avisi’s pivotal clinical trial for VisiPlate, a novel glaucoma treatment. device
Verismo Therapeutics Receives $28 million to Accelerate KIR-CAR Clinical Development
The funding from HLB Innovation, Verismo’s parent company, will advance clinical development of its killer cell immunoglobulin-like receptor (KIR)-chimeric antigen receptor (CAR) platform\.